Dennis Kupitz's research works | Otto-von-Guericke-Universität Magdeburg, Magdeburg (OvGU) and other places
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
PDF) Safety of Repeated Radioembolizations in Patients with Advanced Primary and Secondary Liver Tumors and Progressive Disease After First Selective Internal Radiotherapy
Image-guided Interstitial Brachytherapy in the Management of Metastasized Anal Squamous Cell Carcinoma
Jazan OMARI | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU
Jazan OMARI | Otto-von-Guericke-Universität Magdeburg, Magdeburg | OvGU
PDF) SIRT and Its Unresolved Problems—Is Imaging the Solution? A Review
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
Reply to: “Toxicity and dosimetry in SORAMIC study”
Importante estudio sobre cuidados paliativos en cáncer de hígado finaliza inscripción de cohorte
PDF) Superficial skin cancer therapy with Y-90 microspheres: A feasibility study on patch preparation
SIRT and Its Unresolved Problems—Is Imaging the Solution? A Review
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sora
CARS 2019 Preliminary Program
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma - Journal of Hepatology
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
International Healthcare Vision 2037. New Technologies, Educational Goals and Entrepreneurial Challenges
Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: outcome assessment applying a predictive scoring system | BMC Cancer | Full Text
Radioablation of Hepatic Metastases from Renal Cell Carcinoma With Image-guided Interstitial Brachytherapy
Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers. - Abstract - Europe PMC
PDF) Y90 Radioembolization in chemo-refractory metastastic, liver dominant colorectal cancer patients: Outcome assessment applying a predictive scoring system
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres | SpringerLink
Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios
PDF) Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival
Otto-von-Guericke University of Magdeburg | Department of Gastroenterology, Hepatology & Infectious Diseases - Academia.edu
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization
